EUVIMEDEUVIMED entdecken
Crossref

Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii

Hela Chihi, Amel Bourouis, Karim Naghmouchi, Kamel Ben-Mehrez

Journal of Progressive Medical Sciences · 28.02.2026 · 1 (4)

DOI: 10.63939/0h70qx09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Progressive Medical Sciences, online erschienen am 28.02.2026. Verfasst von Hela Chihi und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global rise in carbapenem resistance in Acinetobacter baumannii is alarming, as it severely restricts available therapeutic options. Among the resistance mechanisms identified in this species, carbapenem-hydrolyzing class D β-lactamases (CHDLs) represent the most prevalent β-lactamases and are largely specific to A. baumannii. This review focuses on the different clusters of oxacillinases that have been reported in Acinetobacter baumannii worldwide. Keywords: Acinetobacter baumannii, CHDLs, carbapenem-hydrolyzing, β-lactamases.

Zitieren

APA

Chihi, H., Bourouis, A., Naghmouchi, K., & Ben-Mehrez, K. (2026). Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii. Journal of Progressive Medical Sciences, 1(4). https://doi.org/10.63939/0h70qx09

Vancouver

Chihi H, Bourouis A, Naghmouchi K, Ben-Mehrez K. Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii. Journal of Progressive Medical Sciences. 2026;1(4). doi:10.63939/0h70qx09

BibTeX
@article{Chihi2026,
  author = {Chihi, Hela and Bourouis, Amel and Naghmouchi, Karim and Ben-Mehrez, Kamel},
  title = {Carbapenem Hydrolysing Oxacillinase in Acinetobacter baumannii},
  journal = {Journal of Progressive Medical Sciences},
  year = {2026},
  volume = {1},
  number = {4},
  doi = {10.63939/0h70qx09}
}
Kostenlos starten →